Global InformationLianhua Qingwen information
 | This article needs attention from an expert in Medicine. The specific problem is: expansion needed. (January 2023) |
| Alternative medicine | |
|---|---|
 | |
| Classification | Traditional Chinese medicine (TCM) |
| Modality | Capsule and granular |
| Claims | Treatment against various respiratory diseases including influenza, severe acute respiratory syndrome, and COVID-19 |
| Year proposed | 2003 |
| Original proponents | Shijiazhuang Yiling Pharmaceutical |
Lianhua Qingwen (simplified Chinese: 连花清瘟; traditional Chinese: 連花清瘟; lit. 'medicine using Forsythia suspensa and Lonicera japonica to clear illness',[1] LHQW) is a traditional Chinese medicine (TCM) formulation used for the treatment of influenza.[2] In the practice of TCM, LHQW is considered to have the effects of clearing excessive heat, removing toxins, improving lung ventilation, and discharging heat.[3]
- ^ Liang, Xinlu (31 March 2022). "How traditional Chinese medicine – TCM – is used to treat Covid-19". South China Morning Post. Retrieved 7 January 2023.
- ^ Shen X, Yin F (October 2021). "The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule". Biomedicine & Pharmacotherapy. 142: 111998. doi:10.1016/j.biopha.2021.111998. PMC 8352581. PMID 34385103.
- ^ Jia, Zhenhua; Wu, Yiling (2021-04-01). "Clinical applications and pharmacological research progress of Lianhua Qingwen capsules/granules". Journal of Traditional Chinese Medical Sciences. 8 (2): 101–109. doi:10.1016/j.jtcms.2021.05.001. ISSN 2095-7548. S2CID 236600045.